Show simple item record

Human Pancreatic Acinar Cells Do Not Respond to Cholecystokinin

dc.contributor.authorJi, Baoanen_US
dc.contributor.authorBi, Yanen_US
dc.contributor.authorSimeone, Diane M.en_US
dc.contributor.authorMortensen, Richard M.en_US
dc.contributor.authorLogsdon, Craig D.en_US
dc.date.accessioned2010-06-01T20:48:14Z
dc.date.available2010-06-01T20:48:14Z
dc.date.issued2002-12en_US
dc.identifier.citationJi, Baoan; Bi, Yan; Simeone, Diane; Mortensen, Richard M.; Logsdon, Craig D. (2002). "Human Pancreatic Acinar Cells Do Not Respond to Cholecystokinin." Pharmacology & Toxicology 91(6): 327-332. <http://hdl.handle.net/2027.42/73903>en_US
dc.identifier.issn0901-9928en_US
dc.identifier.issn1600-0773en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/73903
dc.description.abstractPancreatic secretion can be influenced by cholecystokinin (CCK) either directly via actions on acinar cells or indirectly via actions on nerves. The presence and functional roles of CCK receptors on human pancreatic acinar cells remains unclear. In the current study human pancreatic acini were isolated and then treated with CCK-8, gastrin and/or carbachol. Functional parameters were measured including intracellular [Ca2+] and amylase secretion. It was observed that human acini did not respond to CCK agonists but did respond to carbachol with robust increases in functional parameters. Adenoviral-mediated gene transfer of CCK1 or CCK2 receptors to the human cells resulted in cell responses to CCK agonists. In order to determine the reason for the lack of responsiveness of the human acini, expression of receptor mRNAs was determined using quantitative RT-PCR and localized by in situ hybridization. mRNA levels for CCK1 receptors were ∼30 times lower than those of CCK2 receptors, which were ∼10 times lower than those of m3 Ach receptors as measured by quantitative PCR. Neither CCK1 nor CCK2 receptors were localized in adult human pancreas by i n situ hybridization. These results indicate that human pancreatic acinar cells do not respond directly to CCK receptor activation and this is likely due to an insufficient level of receptor expression.en_US
dc.format.extent171192 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherMunksgaard International Publishersen_US
dc.publisherBlackwell Publishing Ltden_US
dc.rights© Pharmacology & Toxicology 2002en_US
dc.titleHuman Pancreatic Acinar Cells Do Not Respond to Cholecystokininen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelPharmacy and Pharmacologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Surgery, University of Michigan, Ann Arbor, MI 48109-0622, U.S.A.en_US
dc.contributor.affiliationotherDepartment of Physiology, anden_US
dc.identifier.pmid12688376en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/73903/1/j.1600-0773.2002.910610.x.pdf
dc.identifier.doi10.1034/j.1600-0773.2002.910610.xen_US
dc.identifier.sourcePharmacology & Toxicologyen_US
dc.identifier.citedreferenceHarper, A. A. & H. S. Raper: Pancreozymin, a stimulant of the secretion of pancreatic enzymes in extracts of the small intestine. J. Physiol. 1943, 102, 115 – 125.en_US
dc.identifier.citedreferenceNiederau, C., R. Luthen & T. Heintges: Effects of CCK on pancreatic function and morphology. Ann. N. Y. Acad. Sci. 1994, 713, 180 – 198.en_US
dc.identifier.citedreferenceAdler, G.: Regulation of human pancreatic secretion. Digestion 1997, 58 Suppl 1, 39 – 41.en_US
dc.identifier.citedreferenceOwyang, C.: Physiological mechanisms of cholecystokinin action on pancreatic secretion. Amer. J. Physiol. 1996, 271, G1 – G7.en_US
dc.identifier.citedreferenceWank, S. A.: Cholecystokinin receptors. Amer. J. Physiol. 1995, 269, G628 – G646.en_US
dc.identifier.citedreferenceJensen, R. T., S. A. Wank, W. H. Rowley, S. Sato & J. D. Gardner: Interaction of CCK with pancreatic acinar cells. Trends Pharmacol. Sci. 1989, 10, 418 – 423.en_US
dc.identifier.citedreferenceMiller, L. J.: Does the human pancreas have a type A or B personality? Gastroenterology 1996, 111, 1767 – 1770.en_US
dc.identifier.citedreferenceJi, B., Y. Bi, D. Simeone, R. M. Mortensen & C. D. Logsdon: Human pancreatic acinar cells lack functional responses to cholecystokinin and gastrin. Gastroenterology 2001, 121, 1380 – 1390.en_US
dc.identifier.citedreferenceJi, B., A. S. Kopin & C. D. Logsdon: Species differences between rat and mouse CCKA receptors determine the divergent acinar cell response to the cholecystokinin analog JMV-180. J. Biol. Chem. 2000, 275, 19115 – 19120.en_US
dc.identifier.citedreferenceHiguchi, R., C. Fockler, G. Dollinger & R. Watson: Kinetic PCR analysis: real-time monitoring of DNA amplification reactions. Bio/Technology 1993, 11, 1026 – 1030.en_US
dc.identifier.citedreferenceSwift, G. H., R. E. Hammer, R. J. MacDonald & R. L. Brinster: Tissue-specific expression of the rat pancreatic elastase I gene in transgenic mice. Cell 1984, 38, 639 – 646.en_US
dc.identifier.citedreferencePanoskaltsis-Mortari, A. & R. P. Bucy: In situ hybridization with digoxigenin-labeled RNA probes: facts and artifacts. Biotechniques 1995, 18, 300 – 307.en_US
dc.identifier.citedreferenceSusini, C., A. Estival, J. L. Scemama, C. Ruellan, N. Vaysse, F. Clemente, J. P. Esteve, D. Fourmy & A. Ribet: Studies on human pancreatic acini: action of secretagogues on amylase release and cellular cyclic AMP accumulation. Pancreas 1986, 1, 124 – 129.en_US
dc.identifier.citedreferenceLiddle, R. A., I. D. Goldfine, M. S. Rosen, R. A. Taplitz & J. A. Williams: Cholecystokinin bioactivity in human plasma. Molecular forms, responses to feeding, and relationship to gallbladder contraction. J. Clin. Invest. 1985, 75, 1144 – 1152.en_US
dc.identifier.citedreferenceMonstein, H. J., A. G. Nylander, A. Salehi, D. Chen, I. Lundquist & R. Hakanson: Cholecystokinin-A and cholecystokinin-B/gastrin receptor mRNA expression in the gastrointestinal tract and pancreas of the rat and man. A polymerase chain reaction study. Scand. J. Gastroenterol. 1996, 31, 383 – 390.en_US
dc.identifier.citedreferenceCantor, P., L. Petronijevic, J. F. Pedersen & H. Worning: Cholecystokinetic and pancreozymic effect of O-sulfated gastrin compared with nonsulfated gastrin and cholecystokinin. Gastroenterology 1986, 91, 1154 – 1163.en_US
dc.identifier.citedreferenceValenzuela, J. E., J. H. Walsh & J. I. Isenberg: Effect of gastrin on pancreatic enzyme secretion and gallbladder emptying in man. Gastroenterology 1976, 71, 409 – 411.en_US
dc.identifier.citedreferenceCantor, P., O. Olsen, B. J. Gertz, I. Gjorup & H. Worning: Inhibition of cholecystokinin-stimulated pancreaticobiliary output in man by the cholecystokinin receptor antagonist MK-329. Scand. J. Gastroenterol. 1991, 26, 627 – 637.en_US
dc.identifier.citedreferenceCantor, P., P. E. Mortensen, J. Myhre, I. Gjorup, H. Worning, E. Stahl & T. T. Survill: The effect of the cholecystokinin receptor antagonist MK-329 on meal-stimulated pancreaticobiliary output in humans. Gastroenterology 1992, 102, 1742 – 1751.en_US
dc.identifier.citedreferenceTang, C., I. Biemond & C. B. Lamers: Cholecystokinin receptors in human pancreas and gallbladder muscle: a comparative study. Gastroenterology 1996, 111, 1621 – 1626.en_US
dc.identifier.citedreferenceMoriarty, P., Dimaline R, D. G. Thompson & G. J. Dockray: Characterization of cholecystokininA and cholecystokininB receptors expressed by vagal afferent neurons. Neuroscience 1997, 79, 905 – 913.en_US
dc.identifier.citedreferenceSoudah, H. C., Y. Lu, W. L. Hasler & C. Owyang: Cholecystokinin at physiological levels evokes pancreatic enzyme secretion via a cholinergic pathway. Amer. J. Physiol. 1992, 263, G102 – G107.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.